EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in the understanding and management of leiomyomatosis peritonealis disseminata: A narrative review

Xiaoyue Xu iD, Naiyu Liu, Shuxi Liu, Xiaoting Fang, Hong Chen iD

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.70154 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Xiaoyue Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Guangxi, Medical University, Nanning, China. Hauptthemen laut MEDLINE: Leiomyomatosis, Peritoneal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Health Commission of Guangxi Zhuang Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leiomyomatosis peritonealis disseminata (LPD) is a rare gynecologic disorder characterized by the presence of multiple smooth muscle nodules dispersed across the peritoneal surface. While its precise cause remains unknown, studies indicate a role for hormonal, genetic, and molecular influences in disease progression. Advances in imaging, particularly magnetic resonance imaging (MRI) and computed tomography (CT), have enhanced diagnostic precision by differentiating LPD from malignancies, while immunohistochemical markers like smooth muscle actin (SMA), desmin, and estrogen/progesterone receptors (ER/PR) offer valuable pathologic insights. Management strategies include hormonal therapy (e.g., gonadotropin‐releasing hormone [GnRH] agonists) and surgical intervention, with treatment plans tailored to disease severity and patient‐specific factors. Emerging research suggests the potential role of targeted molecular therapies in managing refractory cases. Despite these advances, LPD remains a complex condition, and further research is needed to clarify its pathogenesis, identify reliable biomarkers, and establish standardized treatment protocols. This review synthesizes current knowledge on LPD to enhance clinical awareness and guide future research on its pathogenesis, biomarkers, and treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeiomyomatosisPeritoneal NeoplasmsHumansFemaleMagnetic Resonance ImagingTomography, X-Ray ComputedBiomarkers, Tumor

Stichwörter der Autor:innen

leiomyomatosis peritonealis disseminatamanagementmechanismsmooth muscle tumors

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Guangxi, Medical University, Nanning, China.

ORCID-Profile: Xiaoyue Xu, Hong Chen

Förderung

  • Health Commission of Guangxi Zhuang Autonomous Region

Zitieren

APA

Xu, X., Liu, N., Liu, S., Fang, X., & Chen, H. (2025). Advances in the understanding and management of leiomyomatosis peritonealis disseminata: A narrative review. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70154

Vancouver

Xu X, Liu N, Liu S, Fang X, Chen H. Advances in the understanding and management of leiomyomatosis peritonealis disseminata: A narrative review. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70154

BibTeX
@article{Xu2025,
  author = {Xu, Xiaoyue and Liu, Naiyu and Liu, Shuxi and Fang, Xiaoting and Chen, Hong},
  title = {Advances in the understanding and management of leiomyomatosis peritonealis disseminata: A narrative review},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.70154}
}
Kostenlos starten →